Periodic Reporting for period 2 - GlucoSet (Microsensor for continuous arterial blood glucose monitoring)
Reporting period: 2019-10-01 to 2020-11-30
The overall objective of the project is to develop the product so that it is ready for CE-mark and commercial use in European hospitals. This will be avchieved by first doing a feasibility study in patients, then making any required revisions to the product based on findings in the feasibility trial, and finally doing a test that gives enough clinical evidence for market access. This is all part of the Horizon 2020 project.
The project generated evidence of safe design, high performance and good usability.
The project is expected to have significant socio-economic impact on healthcare costs through the reduced treatment costs of and improved treatment outcomes of ICU patients, although this will not come to pass until after the end of the project.